Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | BAD | Q92934 | 1/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23704623 | 0.98 | PNMT (0.43) | TSHRPNMTHPGDNPC1RAB9A | |
| SCHEMBL29576506 | 0.96 | PNMT (0.44) | TSHRPNMTHPGDNPC1RAB9A | |
| SCHEMBL22263591 | 0.83 | PNMT (0.57) | PNMTHPGDNPC1RAB9AALDH1A1 | |
| SCHEMBL30566335 | 0.81 | ALDH1A1 (0.52) | TSHRPNMTHPGDNPC1RAB9A | |
| SCHEMBL8941775 | 0.81 | CYP2A6 (0.47) | TSHRHPGDL3MBTL1BCL2L1BAD | |
| SCHEMBL28852797 | 0.77 | TSHR (0.44) | TSHRHPGDNPC1RAB9AALDH1A1 | |
| SCHEMBL4974372 | 0.77 | BCL2L1 (0.60) | TSHRHPGDALDH1A1KDM4ELMNA | |
| SCHEMBL20402090 | 0.77 | MAOA (0.56) | PNMTHPGDNPC1RAB9AALDH1A1 | |
| Bromide SCHEMBL7104246 | 0.74 | BCL2L1 (0.58) | TSHRHPGDALDH1A1KDM4ELMNA | |
| SCHEMBL524602 | 0.74 | PNMT (0.63) | PNMTHPGDNPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268015-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2025-08-21 | — | — | US | disclosed |
| EP-4265624-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | Lg Chem, Ltd. (KR) | 2023-10-25 | — | — | EP | disclosed |
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | LG CHEM, LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| EP-4194460-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | Lg Chem, Ltd. (KR) | 2023-06-14 | — | — | EP | disclosed |
| CN-115989725-A | Compound and organic light emitting device including the same | 株式会社LG化学 | 2023-04-18 | — | — | CN | disclosed |
| CN-115968592-A | Organic light emitting device comprising organic compound | 株式会社LG化学 | 2023-04-14 | — | — | CN | disclosed |
| CN-115135662-A | Iridium complex compound, composition containing iridium complex compound, organic electroluminescent element and method for producing same, organic EL display device, and organic EL lighting device | 三菱化学株式会社 | 2022-09-30 | — | — | CN | disclosed |
| WO-2022139513-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022139525-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | 주식회사 엘지화학 | 2022-06-30 | — | — | WO | disclosed |
| EP-2203055-A1 | 1-METHYL NICOTINAMIDE AND DERIVATIVES FOR TREATMENT OF GASTRIC INJURY | Cortria Corporation (US) | 2010-07-07 | — | — | EP | disclosed |
| US-7304155-B2 | Tetrahydrobenzfluorene derivatives | N.V. ORGANON (NL) | 2007-12-04 | — | — | US | disclosed |
| US-20050119264-A1 | Tetrahydrobenzfluorene derivatives | MERCK SHARP & DOHME B.V. (NL) | 2005-06-02 | — | — | US | disclosed |
| US-20050119264-A1 | Tetrahydrobenzfluorene derivatives | MERCK SHARP & DOHME B.V. (NL) | 2005-06-02 | — | — | US | disclosed |
| EP-1458743-A1 | TETRAHYDROBENZFLUORENE DERIVATIVES | Akzo Nobel N.V. (NL) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003053994-A1 | TETRAHYDROBENZFLUORENE DERIVATIVES | AKZO NOBEL N.V. (NL) | 2003-07-03 | — | — | WO | disclosed |
| EP-0832883-B1 | Tetrahydrobenzo(a)fluorene compounds and methods of use | LILLY CO ELI (US) | 2002-04-03 | — | — | EP | disclosed |
| EP-0832883-B1 | Tetrahydrobenzo(a)fluorene compounds and methods of use | LILLY CO ELI (US) | 2002-04-03 | — | — | EP | disclosed |
| EP-0832883-A1 | Tetrahydrobenzo(a)fluorene compounds and methods of use | ELI LILLY AND COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0832883-A1 | Tetrahydrobenzo(a)fluorene compounds and methods of use | ELI LILLY AND COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0832883-A1 | Tetrahydrobenzo(a)fluorene compounds and methods of use | ELI LILLY AND COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | CYP1A1, AOX1, CYP1B1 | TSHR 3909/4885PNMT 1201/4885HPGD 2302/4885 |
| US-20050119264-A1 | Tetrahydrobenzfluorene derivatives | ESR1, ESR2, GPER1 | TSHR 129/4885PNMT 2136/4885HPGD 1922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.